Furthermore, when comparing expression levels of BET proteins, we found that BRD2 showed higher expression levels compared to BRD3 and BRD4 in the three cell lines, suggesting that BRD2 could be a major target of (+)-JQ1 in canine mammary cancers. This evidence concerns the gene BRD3 and breast cancer.